Latest News

Viking Therapeutics Completes Enrollment for Phase 2 Trial of Oral Tablet for Obesity / image credit ©Viking Therapeutics
Viking Therapeutics Completes Enrollment for Phase 2 Trial of Oral Obesity Tablet

March 26th 2025

Data from the phase 2 VENTURE-Oral Dosing Trial of VK2735 is expected in the second half of the year, the company said.

Investigational Keto Diet Pill Shows Promise in Phase 1 Trial: Daily Dose / image credit: ©New Africa/AdobeStock
Investigational Keto Diet Pill Shows Promise in Phase 1 Trial: Daily Dose

March 21st 2025

Massive Trump Administration Cuts to Federal Grants Halt National Diabetes Prevention Program  / image credit ©Centers for Disease Control and Prevention
Massive Trump Administration Cuts to Federal Grants Halt National Diabetes Prevention Program

March 19th 2025

ZUPREME-1 Phase 2b Trial of Petrelentide for Obesity Completes Enrollment / image credit ©Vitalii Vodolazskyi/stock.adobe.com
ZUPREME-1 Phase 2b Trial of Petrelentide for Obesity Completes Enrollment

March 19th 2025

Osteoporosis Risk Screening Tools Fall Short in Younger Postmenopausal Women, New Research Reveals
Osteoporosis Risk Screening Tools Fall Short in Younger Postmenopausal Women, New Research Reveals

March 18th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.